Stocks Screener

Specify Company / Ticker to Get the Summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Dividend History LLY

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021

Dividend Analytics LLY

Champion - 10+ consecutive years of dividend increases

Max Ratio

2.39 %

5Y Dividend Growth

102.00 %

Consecutive Years

10 years

5Y Average Payout Ratio

55.65 %
Forward Annual Dividend Yield 0.78 %
Consecutive Years 10
Forward Annual Dividend 6.00 USD
Consistent Years 34
Dividend CAGR 3Y 15.21 %
Continuous Dividends 53
Dividend CAGR 5Y 15.05 %
Payout Ratio TTM 40.70 %
Dividend CAGR 10Y 10.25 %
Ex Dividend Date 16.05.2025

Eli Lilly and Company

LLY
Current price
770.64 USD +0.11 USD (+0.01%)
Last closed 762.73 USD
ISIN US5324571083
Sector Healthcare
Industry Drug Manufacturers - General
Exchange NYSE
Capitalization 684 730 155 008 USD
Yield for 12 month -13.42 %
1Y
3Y
5Y
10Y
15Y
LLY
21.11.2021 - 28.11.2021

Eli Lilly and Company discovers, develops, and markets human pharmaceuticals in the United States, Europe, China, Japan, and internationally. The company offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; Jardiance, Mounjaro, and Trulicity for type 2 diabetes; and Zepbound for obesity. It also provides oncology products, including Alimta, Cyramza, Erbitux, Jaypirca, Retevmo, Tyvyt, and Verzenio. In addition, the company offers Olumiant for rheumatoid arthritis, atopic dermatitis, severe alopecia areata, and COVID-19; Taltz for plaque psoriasis, psoriatic arthritis, ankylosing spondylitis, and non-radiographic axial spondylarthritis; Omvoh for ulcerative colitis; Cymbalta for depressive disorder, diabetic peripheral neuropathic pain, generalized anxiety disorder, fibromyalgia, and chronic musculoskeletal pain; Ebglyss for severe atopic dermatitis; and Emgality for migraine prevention and episodic cluster headache. It has collaborations with Incyte Corporation; Boehringer Ingelheim Pharmaceuticals, Inc.; F. Hoffmann-La Roche Ltd and Genentech, Inc.; Biologics, Inc., AbCellera Biologics Inc.; Verge Genomics; collaboration with AdvanCell to advance novel targeted alpha therapies for the treatment of cancer; and Chugai Pharmaceutical Co., Ltd. Eli Lilly and Company was founded in 1876 and is headquartered in Indianapolis, Indiana. Address: Lilly Corporate Center, Indianapolis, IN, United States, 46285

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

951.98 USD

P/E ratio

62.11

Dividend Yield

0.78 %

Financials LLY

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Key Figures LLY

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021

Current Year

+45 042 700 000 USD

Last Year

+34 124 100 000 USD

Current Quarter

+12 728 500 000 USD

Last Quarter

+13 532 800 000 USD

Current Year

+36 624 400 000 USD

Last Year

+27 041 900 000 USD

Current Quarter

+10 504 300 000 USD

Last Quarter

+11 129 000 000 USD
EBITDA 22 003 300 352 USD
Operating Margin TTM 42.49 %
Price to Earnings 62.11
Return On Assets TTM 16.45 %
PEG Ratio 1.17
Return On Equity TTM 77.28 %
Wall Street Target Price 951.98 USD
Revenue TTM 49 003 200 512 USD
Book Value 16.64 USD
Revenue Per Share TTM
Dividend Share 5.40 USD
Quarterly Revenue Growth YOY 45.20 %
Dividend Yield 0.78 %
Gross Profit TTM 40 034 201 600 USD
Earnings per share 12.28 USD
Diluted Eps TTM 12.28 USD
Most Recent Quarter I 2025
Quarterly Earnings Growth YOY 23.40 %
Profit Margin 22.67 %

Stock Valuation LLY

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE 62.11
Forward PE 34.97
Enterprise Value Revenue 14.69
Price Sales TTM 13.97
Enterprise Value EBITDA 44.24
Price Book MRQ 43.43

Technical indicators LLY

For 52 weeks

675.71 USD 967.27 USD
50 Day MA 777.73 USD
Shares Short Prior Month 7 352 058
200 Day MA 823.62 USD
Short Ratio 1.58
Shares Short 8 028 911
Short Percent 1.00 %